Anti-TNF antibody approved for Crohn's disease.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003424:Crohn Disease / Q000188:drug therapy*; D017277:Drug Approval; D006801:Humans; D000069285:Infliximab; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*; D014481:United States; D014486:United States Food and Drug Administration